The legal action, brought by Pomerantz LLP, centers on claims that DNOW executives failed to disclose material complications surrounding the MRC Global integration. According to the filing, the company allegedly understated the difficulties of the merger, rendering public statements regarding the firm's business and operational prospects false or lacking a reasonable basis. The lawsuit targets the period leading up to the special meeting held on September 9, 2025, where shareholders voted on the acquisition.
Investors who purchased or acquired DNOW securities during the relevant class period have until October 2, 2026, to petition the court for appointment as Lead Plaintiff. Those seeking to participate in the litigation or review the complaint can contact Danielle Peyton at Pomerantz LLP. The firm, which specializes in securities and corporate misconduct, is currently soliciting information from affected shareholders regarding their purchase history and contact details.



Comments (0)
No comments yet. Be the first!